| State-of-the-art: Boehringer Ingelheim’s R
& D approaches and techniques
Boehringer Ingelheim's successful drug discovery also relies on
excellent interdisciplinary cooperation and well-functioning
medicinal chemistry with state-of-the-art
combinatorial chemistry
chemoinformatics
diversified chemical library
efficient biopharmaceutical development.
Technologies and approaches such as genomics, proteomics, bioinformatics, e-R & D, ultra high-throughput screening and modern galenical and device development are today
vital for successful Research & Development.
Targeting new territory - genomics, proteomics, bioinformatics, e-R & D, Ultra high-throughput screening
e-R & D - Mastering the data flood
Ultra high-throughput screening
Ultra high-throughput screening, as testing system, allows up to
100,000 tests to be performed per day.
Combinatorial chemistry
New imaging techniques to
analyse tests, further reduction in size of titre plates, reduction
in amount of substance required and new technologies for data
evaluation including artifical intelligence, comprise the next steps
in development to further modernize screening of substance pools and
substance libraries compiled by means of combinatorial chemistry.
|
|
|
